| 日付 | 受信時刻 | ニュースソース | 見出し | コード | 企業名 |
| 2008/10/10 | 02 : 03 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/10/06 | 21 : 30 | Marketwired | Pipex Pharmaceuticals to Present at the Maxim Group Growth Conference on October 7th | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/09/19 | 21 : 30 | Marketwired | Pipex Pharmaceuticals' Oral TRIMESTA Phase IIa Clinical and Preclinical Findings Presented at World Congress on Treatment and Re | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/08/30 | 06 : 01 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Amended Annual Report (Small Business Issuers) (10KSB/A) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/08/19 | 21 : 54 | Marketwired | Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate for Rheumatoid Arthritis | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/08/19 | 21 : 30 | Marketwired | Pipex Pharmaceuticals, Inc. to Present at the RedChip Small Cap Investor Conference in New York City | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/08/15 | 05 : 49 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/08/15 | 05 : 18 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/08/15 | 02 : 39 | Marketwired | Pipex Pharmaceuticals Announces Clinical Update and Second Quarter 2008 Results | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/08/12 | 21 : 27 | Marketwired | Pipex Pharmaceuticals to Present at the Noble Financial Equity Conference | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/07/15 | 21 : 40 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Amended Statement of Beneficial Ownership (SC 13D/A) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/07/15 | 07 : 45 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/07/10 | 03 : 48 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/07/09 | 21 : 38 | Marketwired | Pipex Pharmaceuticals Announces Results of Eighty Patient, Six Month, Prospective, Randomized, Double-Blind Clinical Trial of Or | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/07/09 | 06 : 16 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/07/09 | 04 : 54 | Marketwired | Pipex Pharmaceuticals to Host Conference Call at 10:15am ET Wednesday July 9th to Discuss Phase II Clinical Trial Results in Dry | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/07/08 | 20 : 41 | Marketwired | Pipex Pharmaceuticals Appoints Co-Founder and Vice Chairman Nicholas Stergis as Chief Executive Officer | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/05/20 | 22 : 00 | Marketwired | Pipex Pharmaceuticals Announces Issuance of Additional US Patent Covering CD4 Inhibitor Molecules | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/05/16 | 23 : 59 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/05/16 | 06 : 13 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Quarterly Report (10-Q) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/05/16 | 05 : 36 | Marketwired | Pipex Pharmaceuticals Announces Clinical Update and First Quarter 2008 Results | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/05/13 | 22 : 05 | Marketwired | Pipex Pharmaceuticals to Provide Clinical Update and Report First Quarter 2008 Results on Thursday, May 15 | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/05/12 | 22 : 23 | Marketwired | Pipex Pharmaceuticals Receives FDA Orphan Drug Designation for Oral TTM for Idiopathic Pulmonary Fibrosis (IPF) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/05/07 | 22 : 00 | Marketwired | Pipex Pharmaceuticals Announces Notice of Allowance of U.S. Patent for Oral TTM for Alzheimer's Disease | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/05/02 | 21 : 38 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/04/30 | 04 : 35 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Proxy Statement (definitive) (DEF 14A) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/04/21 | 21 : 02 | Marketwired | Pipex Pharmaceuticals' Oral Flupirtine Receives IND With FDA for Phase II Clinical Trial for Fibromyalgia | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/04/19 | 06 : 13 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/04/16 | 00 : 12 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Statement of Changes in Beneficial Ownership (4) | AMEX:PP | Meet Kevin Pricing Power ETF |
| 2008/04/02 | 02 : 49 | Edgar (US Regulatory) | Pipex Pharmaceuticals, Inc. - Current report filing (8-K) | AMEX:PP | Meet Kevin Pricing Power ETF |